Featured Research

from universities, journals, and other organizations

Clonal Human Neurons Re-Establish Connection In Rats With Severe Spinal Cord Injury

Date:
July 2, 2002
Source:
University Of South Florida Health Sciences Center
Summary:
Human neurons grown as cells cloned from a tumor helped restore the function of severely injured spinal cords in rats, University of South Florida researchers say in a study released this week in the Journal of Neurosurgery: Spine.

Tampa, FL (July 1, 2002) — Human neurons grown as cells cloned from a tumor helped restore the function of severely injured spinal cords in rats, University of South Florida researchers say in a study released this week in the Journal of Neurosurgery: Spine.

Related Articles


"Transplants of these specially treated cells were used to patch a short circuit in the spinal cord of rats," said Samuel Saporta, PhD, associate director of the USF Center for Aging and Brain Repair, professor of anatomy and lead author of the study. "We demonstrated the cells are safe, survive and can electrically reconnect the undamaged parts of the spinal cord."

A couple of the spinal cord-injured (SCI) rats could bear weight on their hind legs following transplantation with the experimental cells, known commercially as hNT, or LBS, neurons. However, the researchers emphasize, more studies are needed to determine if rats with reconnected spinal cords can walk again.

"We are hopeful that our work with hNT neurons in an animal model for spinal cord injury will ultimately lead to the first transplant of human neural progenitor cells to treat spinal cord injury in humans," said neuroscientist Paul R. Sanberg, PhD, DSc, director of the USF Center for Aging and Brain Repair and a study co-author.

Dr. Saporta, Dr. Sanberg and colleagues at USF conducted preclinical research with hNT neurons that led to the first transplant to repair brain damage from stroke in 1998. That clinical trial, ongoing at the University of Pittsburgh Medical Center, has shown initial promise in improving the function of a small group of stroke patients.

HNT neurons originate from a rare human cancer characterized by the presence of immature or "progenitor" cells. These rapidly dividing tumor cells have the capacity to differentiate into neurons, each a clone of the original cells.

The cells can be treated with retinoic acid in the laboratory to prompt them into becoming fully committd, non-dividing neurons. Research in both animals and humans has shown that these hNT neurons do not revert to cancer cells.

The USF team studied three groups of rats with severe SCI. One group was administered hNT neurons immediately following injury, another received transplants two weeks after SCI injury, and the third, a control group, received no transplant.

The spinal cord, which runs from the brain to the end of the spine, is like an electrical circuit that sends messages to and from the brain to the rest of the body. If the spinal cord is damaged or severed, however, the electrical activity either stops from the point of injury downward or provides faulty messages.

All seven animals in the delayed transplant group recovered electrical activity in the spinal cord neurons that control muscle movement. Only two of nine animals in the immediate transplant group did. In addition this electrical activity — known as motor evoked potentials or MEPs — measured much stronger in the delayed transplant group than in rats receiving hNT neurons immediately after injury. The untreated SCI rats had no improvement in motor neuron transmission.

The researchers suspect that the better recovery results in the animals with delayed transplants, compared to those transplanted right after injury, may be due to a less hostile immune environment as time passes. Immediately following injury, Dr. Saporta said, inflammatory substances called cytokines recruit immune cells to clear all foreign material away from the area of injury — including, perhaps some of the transplanted hNT neurons.

Pathological examination showed that the transplanted hNT neurons, injected into the spinal cord at the site of injury, maintained the characteristics of neurons. The cells sprouted fibers, or axons, that grew into the undamaged, intact portions of the spinal cord above and below the injured area.

Although two transplanted animals were able to bear weight, none of the rats walked following treatment with the dose of hNT neurons administered in this study.

The transplanted cells appear to fill in the area of damage and re-establish a neural connection, Dr. Saporta said. "This suggests it may be possible to teach the spinal cord, through rehabilitation, how to send out appropriate signals to the muscles so the animal can walk again … That's the next step."

Layton BioScience Inc. of Atherton, CA, holds the license for hNT neuron transplantation technology and is developing the cells for the treatment of several neurological disorders.

In addition to Dr. Saporta and Dr. Sanberg, other authors of the study were Shahram Makoui, MD; Alison Willing, PhD, and David Cahill, MD, all of the USF Center for Aging and Brain Repair; and Marcel Daadi, PhD; of Layton Bioscience, Inc.


Story Source:

The above story is based on materials provided by University Of South Florida Health Sciences Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of South Florida Health Sciences Center. "Clonal Human Neurons Re-Establish Connection In Rats With Severe Spinal Cord Injury." ScienceDaily. ScienceDaily, 2 July 2002. <www.sciencedaily.com/releases/2002/07/020702070527.htm>.
University Of South Florida Health Sciences Center. (2002, July 2). Clonal Human Neurons Re-Establish Connection In Rats With Severe Spinal Cord Injury. ScienceDaily. Retrieved November 1, 2014 from www.sciencedaily.com/releases/2002/07/020702070527.htm
University Of South Florida Health Sciences Center. "Clonal Human Neurons Re-Establish Connection In Rats With Severe Spinal Cord Injury." ScienceDaily. www.sciencedaily.com/releases/2002/07/020702070527.htm (accessed November 1, 2014).

Share This



More Health & Medicine News

Saturday, November 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Melafind: Spotting Melanoma Without a Biopsy

Melafind: Spotting Melanoma Without a Biopsy

Ivanhoe (Oct. 31, 2014) The MelaFind device is a pain-free way to check suspicious moles for melanoma, without the need for a biopsy. Video provided by Ivanhoe
Powered by NewsLook.com
Battling Multiple Myeloma

Battling Multiple Myeloma

Ivanhoe (Oct. 31, 2014) The answer isn’t always found in new drugs – repurposing an ‘old’ drug that could mean better multiple myeloma treatment, and hope. Video provided by Ivanhoe
Powered by NewsLook.com
Chronic Inflammation and Prostate Cancer

Chronic Inflammation and Prostate Cancer

Ivanhoe (Oct. 31, 2014) New information that is linking chronic inflammation in the prostate and prostate cancer, which may help doctors and patients prevent cancer in the future. Video provided by Ivanhoe
Powered by NewsLook.com
Sickle Cell: Stopping Kids’ Silent Strokes

Sickle Cell: Stopping Kids’ Silent Strokes

Ivanhoe (Oct. 31, 2014) Blood transfusions are proving crucial to young sickle cell patients by helping prevent strokes, even when there is no outward sign of brain injury. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins